Q2 EPS Forecast for Nurix Therapeutics Raised by Analyst
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) – Stock analysts at Leerink Partnrs raised their Q2 2025 EPS estimates for Nurix Therapeutics in a research report issued on Tuesday, April 8th. Leerink Partnrs analyst F. Khurshid now forecasts that the company will post earnings per share of ($0.84) for the quarter, up from their previous […]
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) – Stock analysts at Leerink Partnrs raised their Q2 2025 EPS estimates for Nurix Therapeutics in a research report issued on Tuesday, April 8th. Leerink Partnrs analyst F. Khurshid now forecasts that the company will post earnings per share of ($0.84) for the quarter, up from their previous […]